{"id":"W2235582661","doi":"10.1200/jco.2007.25.18_suppl.5084","title":"Combination chemotherapy with gemcitabine, oxaliplatin and paclitaxel in patients with cisplatin-refractory or relapsed germ cell tumors (gct)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Oxaliplatin; Gemcitabine; Cisplatin; Chemotherapy; Refractory (planetary science); Internal medicine; Paclitaxel; Oncology; Progressive disease; Gastroenterology; Toxicity; Progression-free survival; Urology; Surgery; Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000518474,0.0004398926,0.001121277,0.0003923454,0.0003594696,0.0004761705,0.0003764028,0.0004596541,0.001019996],"category_scores_gemma":[0.0006138164,0.0002938053,0.0003976025,0.0004729746,0.0002798105,0.0002768882,0.0002761761,0.0006663682,0.0003589405],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005420703,"about_ca_system_score_gemma":0.0005204947,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004655136,"about_ca_topic_score_gemma":0.001554311,"domain_scores_codex":[0.9997229,0.0001253522,0.00002550471,0.00004621183,0.00003587135,0.00004415409],"domain_scores_gemma":[0.9997266,0.00006258527,0.00005420985,0.00002017053,0.00001430563,0.0001220559],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1063324,0.01154598,0.2899669,0.001549791,0.0016169,0.006017935,0.0007145831,0.008059667,0.06764285,0.0002728971,0.00764637,0.4986338],"study_design_scores_gemma":[0.04819459,0.3574812,0.5141858,0.0003295617,0.002218942,0.02103354,0.0002868247,0.009757549,0.01775486,0.0005628938,0.02809633,0.00009803074],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937597,0.00421535,0.0002846643,0.0002068733,0.0000388835,0.0001960259,0.0001238425,0.00003627328,0.001138477],"genre_scores_gemma":[0.9962411,0.001508981,0.0008870232,0.0002427252,0.00008241597,0.0001968455,0.000446623,0.000008270883,0.000385925],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001121277,"threshold_uncertainty_score":0.003933072,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04387084198947501,"score_gpt":0.4158554860321698,"score_spread":0.3719846440426948,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}